View live charts, options flow & technicals for Intuitive Surgical, Inc. →
Open Dashboard
Intuitive Surgical, Inc. (ISRG) is a healthcare company in the medical instruments & supplies industry with $11.03B in trailing revenue trading at a 46.1× trailing P/E — analyst consensus: buy.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Key Statistics
Market Cap
$142.70B
Revenue (TTM)
$11.03B
EPS (TTM)
$8.64
EPS (Fwd est.)
$12.09
Employees
17,021
Trailing P/E
46.10
Forward P/E
32.94
PEG Ratio
1.87
Price / Sales
12.93
Price / Book
7.76
EV / EBITDA
32.44
Beta (5Y)
1.47
Analyst Consensus
Consensus
Buy
Analyst Price Target
+19.6% upside
Target: $476.34
Annual Revenue & Net Income
RevenueNet Income
'22
$6.22B
'23
$7.12B
'24
$8.35B
'25
$10.06B
Earnings History
Quarter
Actual EPS
Estimate
Result
Jul 2026
$2.80
$2.50
Beat (+11.9%)
Apr 2026
$2.50
$2.11
Beat (+18.7%)
Jan 2026
$2.53
$2.27
Beat (+11.6%)
Oct 2025
$2.40
$1.99
Beat (+20.7%)
Next Earnings Report
Intuitive Surgical, Inc. is next expected to report earnings on 20 Oct 2026.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings …
What is ISRG's market cap?
Intuitive Surgical, Inc. has a market capitalization of approximately $142.70B.
What is ISRG's P/E ratio?
Intuitive Surgical, Inc. trades at a trailing P/E ratio of 46.1x and a forward P/E of 32.9x, which is above the broad market average of ~25x.
How much revenue does ISRG generate?
Intuitive Surgical, Inc. generated $11.03B in trailing 12-month revenue.
What do analysts say about ISRG?
The analyst consensus rating for Intuitive Surgical, Inc. is buy, with a mean price target of $476.34. That implies +19.6% upside from the current price.
When does ISRG report earnings?
Intuitive Surgical, Inc. is next scheduled to report earnings on 20 Oct 2026.
Does ISRG pay a dividend?
Intuitive Surgical, Inc. does not currently pay a regular dividend.
View live charts, options flow, gamma exposure, earnings history, and technical analysis for Intuitive Surgical, Inc. on Apsis Markets.